Am Fam Physician. 2007 Jan 1;75(1):50.
Humidified Air for Croup?
Is humidified air an effective treatment for laryngotracheobronchitis (croup)?
Available data do not support a clinically important benefit of humidified air for symptomatic treatment of children with croup. However, it does not appear to be harmful.
Although humidified air is recommended routinely to parents of children with croup as a way to relieve symptoms, it has not been studied well. In addition, animal studies have found that airway resistance is reduced more by warm or cool dry air than by warm moist air. The authors of this systematic review searched the literature and identified three studies with a total of 135 patients. The number of participants in each study was between 16 and 71, and the overall age range was three months to six years. All studies compared warm or cool humidified air with no treatment, took place in the emergency department or children's ward, and evaluated outcomes using a validated symptom score. The studies were generally of good quality, although only one had outcomes assessed by researchers blinded to the treatment assignment.
The authors combined symptom scores assessed at 20 to 60 minutes and found no significant benefit with humidified air. Although at 20 to 30 minutes, there was a trend toward benefit with mist; at 60 minutes, the trend favored no treatment (effect sizes = −0.4 [95% confidence interval (CI), −0.82 to 0.02] and 0.2 [95% CI, −0.64 to 1.05], respectively).
There are no standard national guidelines for the management of croup in the United States. A guideline from the Alberta Medical Association does not recommend mist therapy because it has not been shown to be effective,1 and an evidence-based guide-line from Monash University in Australia states that mist and humidified air have not been demonstrated to be effective treatments for children with croup.2 Oral dexamethasone (Decadron; 0.6 mg per kg) improves outcomes and reduces the risk of hospital admission. For severe croup with stridor, respiratory distress, or lethargy, blow-by oxygen and nebulized racemic epinephrine 2.25% (0.5 mL in 2.5 mL saline) or L-epinephrine 1:1,000 (0.5 mL) also are treatment options.
Source: Moore M, et al. Humidified air inhalation for treating croup. Cochrane Database Syst Rev 2006;(3): CD002870.
1. Alberta Clinical Practice Guideline Working Group. Diagnosis and management of croup. Edmonton, Alberta: Alberta Medical Association, 2005. Accessed October 24, 2006, at: http://www.topalbertadoctors.org/TOP/CPG/Croup/Croup.htm.
2. Health for Kids in the South East Croup Guideline Development Group. Evidence-based practice guideline for the management of croup in children. Clayton, Victoria, Australia: Monash Institute of Health Services Research, 2006. Accessed October 24, 2006, at: http://www.mihsr.monash.org/hfk/pdf/hfkcroupguidelinefinalweb.pdf.
Copyright © 2007 by the American Academy of Family Physicians.
This content is owned by the AAFP. A person viewing it online may make one printout of the material and may use that printout only for his or her personal, non-commercial reference. This material may not otherwise be downloaded, copied, printed, stored, transmitted or reproduced in any medium, whether now known or later invented, except as authorized in writing by the AAFP. Contact firstname.lastname@example.org for copyright questions and/or permission requests.
Want to use this article elsewhere? Get Permissions
More in AFP
MOST RECENT ISSUE
Feb 15, 2018
Access the latest issue of American Family Physician